Subcutaneous Delivery Articles & Analysis: Older
5 articles found
In 1976, based on microneedle intradermal injection, Gerstel and Place first proposed the concept of microneedle transdermal drug delivery, but in the following two decades, no real microneedles were available for experiments. ...
Three years after Sanofi led its series B, Enable Injections has raised a $215 million round to fund work on subcutaneous drug delivery system enFuse. Enable Injections’ device consists of a wearable delivery disc and a system for transferring the drug from its original vessel. Users put the disc in the transfer system, connect a syringe ...
CEO and president Mike Hooven said the funding: “will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling our development and commercialisation efforts”. ...
However, given the amount of time required per IV placement and the IV placement failure rate, it is not surprising that patients prefer subcutaneous (SC) delivery over IV infusion.4 The Step Forward With SC Administration SC administration enables more flexible delivery options for both the patient and the provider. ...
Improving the constancy of drug delivery is the next frontier for enhancing therapeutic options with levodopa. ...
